VF
LYRA

Virtu Financial’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Virtu Financial’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-841
Closed -$9K – 1745
2024
Q4 		$9K Buy
+841
New +$9.25K ﹤0.01% 1392
2024
Q3 		– Sell
-634
Closed -$9K – 1663
2024
Q2 		$9K Buy
634
+395
+165% +$44.7K ﹤0.01% 1141
2024
Q1 		$74K Buy
+239
New +$63.7K 0.01% 964
2023
Q4 		– Sell
-392
Closed -$77K – 1831
2023
Q3 		$77K Buy
+392
New +$70.1K 0.01% 864
2022
Q1 		– Sell
-263
Closed -$57K – 1796
2021
Q4 		$57K Buy
+263
New +$84.5K 0.01% 1311

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Virtu Financial's LYRA Position: Q1 2025 in Review

Virtu Financial sold out of LYRA THERAPEUTICS INC (LYRA) in Q1 2025, closing a stake of 841 shares — an estimated $9K sold.

Virtu Financial first reported a position in LYRA in Q4 2021 and held it in 5 quarters. The position peaked at $77K in Q3 2023. 57 funds tracked by Wall St. Rank hold LYRA as of Q1 2025.

  • Virtu Financial reported no remaining LYRA THERAPEUTICS INC position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 841 LYRA THERAPEUTICS INC shares in Q1 2025, an estimated $9K.
  • Virtu Financial first reported a position in LYRA THERAPEUTICS INC in Q4 2021 and held it in 5 quarters.
  • Virtu Financial's LYRA THERAPEUTICS INC position peaked at $77K in Q3 2023.
  • 57 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.